Joseph Buxbaum
@jdbux.bsky.social
Director, Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai. Shakuhachi student.
This was certainly not the main point of the post :-) but I see your point and will try to check with the church next time I am on the square. Will edit the post.
October 23, 2025 at 1:41 AM
This was certainly not the main point of the post :-) but I see your point and will try to check with the church next time I am on the square. Will edit the post.
Appropriate clinical testing of leucovorin and evaluating the role of antibodies to the folate receptor as a biomarker are straightforward studies and could have easily been carried out since the underlying hypotheses were first suggested by Dr. Richard Fry. www.thetransmitter.org/spectrum/exc...
Exclusive: Meet Richard Frye, who studies leucovorin for autism
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
www.thetransmitter.org
October 3, 2025 at 1:39 PM
Appropriate clinical testing of leucovorin and evaluating the role of antibodies to the folate receptor as a biomarker are straightforward studies and could have easily been carried out since the underlying hypotheses were first suggested by Dr. Richard Fry. www.thetransmitter.org/spectrum/exc...